Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Alle Spezies anzeigen
Weitere Synonyme anzeigen
Wählen Sie die Spezies und Applikation aus
anti-Mouse (Murine) Antikörper:
anti-Rat (Rattus) Antikörper:
Sie gelangen zu unserer vorgefilterten Suche.
Human Monoclonal HAVCR2 Primary Antibody für FACS - ABIN4896442
Tandon, Giret, Sengupta, York, Wiznia, Rosenberg, Kallas, Ndhlovu, Nixon: Age-related expansion of Tim-3 expressing T cells in vertically HIV-1 infected children. in PLoS ONE 2012
Show all 22 Pubmed References
Human Polyclonal HAVCR2 Primary Antibody für CyTOF, FACS - ABIN4899649
Moller-Tank, Albritton, Rennert, Maury: Characterizing functional domains for TIM-mediated enveloped virus entry. in Journal of virology 2014
Show all 13 Pubmed References
Human Monoclonal HAVCR2 Primary Antibody für FACS - ABIN4896438
Raziorrouh, Heeg, Kurktschiev, Schraut, Zachoval, Wendtner, Wächtler, Spannagl, Denk, Ulsenheimer, Bengsch, Pircher, Diepolder, Grüner, Jung: Inhibitory phenotype of HBV-specific CD4+ T-cells is characterized by high PD-1 expression but absent coregulation of multiple inhibitory molecules. in PLoS ONE 2014
Show all 8 Pubmed References
Human Monoclonal HAVCR2 Primary Antibody für CyTOF, FACS - ABIN4899648
Hertoghs, Moerland, van Stijn, Remmerswaal, Yong, van de Berg, van Ham, Baas, ten Berge, van Lier: Molecular profiling of cytomegalovirus-induced human CD8+ T cell differentiation. in The Journal of clinical investigation 2010
Show all 6 Pubmed References
Human Polyclonal HAVCR2 Primary Antibody für WB - ABIN1881402
Cao, Zhu, Zhu, Li, Zhang, Xu, Zhang: Genetic variations and haplotypes in TIM-3 gene and the risk of gastric cancer. in Cancer immunology, immunotherapy : CII 2010
Show all 5 Pubmed References
Mouse (Murine) Monoclonal HAVCR2 Primary Antibody für FACS - ABIN4896159
Yadav, Jhunjhunwala, Phung, Lupardus, Tanguay, Bumbaca, Franci, Cheung, Fritsche, Weinschenk, Modrusan, Mellman, Lill, Delamarre: Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing. in Nature 2014
Show all 3 Pubmed References
Mouse (Murine) Monoclonal HAVCR2 Primary Antibody für FACS - ABIN4896162
Cho, Roche, Sandall, Brass, Seed, Xavier, Medoff: Enhanced Tim3 activity improves survival after influenza infection. in Journal of immunology (Baltimore, Md. : 1950) 2012
Show all 3 Pubmed References
Human Monoclonal HAVCR2 Primary Antibody für FACS - ABIN4896439
Lasso, Mateus, Pavía, Rosas, Roa, Thomas, López, González, Puerta, Cuéllar: Inhibitory Receptor Expression on CD8+ T Cells Is Linked to Functional Responses against Trypanosoma cruzi Antigens in Chronic Chagasic Patients. in Journal of immunology (Baltimore, Md. : 1950) 2015
Show all 3 Pubmed References
Mouse (Murine) Polyclonal HAVCR2 Primary Antibody für CyTOF, FACS - ABIN4899644
Koh, Chang, Jeon, Yoon, Ahn, Kim, Kim, Jeon, Johnson, Park: The HIF-1/glial TIM-3 axis controls inflammation-associated brain damage under hypoxia. in Nature communications 2015
Show all 2 Pubmed References
Mouse (Murine) Monoclonal HAVCR2 Primary Antibody für IHC (fro), FACS - ABIN2476818
Warner: Tobacco industry scientific advisors: serving society or selling cigarettes? in American journal of public health 1991
Show all 3 Pubmed References
The Tim-3/Gal-9 (zeige LGALS9 Antikörper) pathway might link disease progression with T cell exhaustion during bovine leukemia virus infection.
TIM-3 polymorphism is associated with response to therapy in hepatitis B virus-related hepatocellular carcinoma.
BMI-1 (zeige BMI1 Antikörper), TIM-3 and CLL-1 (zeige COLEC10 Antikörper) have roles in acute myeloid leukemia (zeige BCL11A Antikörper) prognosis and therapy
Quantification of TIM-3 and KIM-1 (zeige HAVCR1 Antikörper) mRNA expressions, along with KIM-1 (zeige HAVCR1 Antikörper) protein measurements in urine and blood could be employed as promising tools for noninvasive diagnosis of allograft dysfunction.
Results show that human acute myeloid leukemia (zeige BCL11A Antikörper) (AML (zeige RUNX1 Antikörper)) cells possess a secretory pathway which leads to the production and release of soluble Tim-3 and galectin-9 (zeige LGALS9 Antikörper). Both proteins prevent the activation of NK cells and impair their AML (zeige RUNX1 Antikörper) cell-killing activity.
after 14 days of glucocorticoid therapy, clinical findings (serum bilirubin, skin GVHD) and plasma biomarkers (TIM3, ST2, sTNFR1) can predict failure of GVHD treatment and nonrelapse mortality.
These findings suggested that rs10053538 in TIM-3 might increase susceptibility to and promote the progression of breast cancer in Chinese women
Results indicate that T cell Ig and mucin domain 3 protein (TIM-3) polymorphisms (-1516G/T, -574G/T, and +4259T/G) were associated with the increased risk of cancer in Chinese Han population.
In cultured MART1 (zeige MLANA Antikörper)-specific CD8 (zeige CD8A Antikörper) T cells stimulated with peptide-loaded artificial antigen-presenting cells, anti-TIM-3 antibody treatment promotes generation of effector T cells, with acquisition of an activated phenotype, increased cytokine production, enhanced proliferation, and a transcription program associated with T cell differentiation. Anti-TIM-3 drives CD8 (zeige CD8A Antikörper) T cell differentiation through activation of mTORC1.
Our results show that Tim-3 is a critical negative regulator of NLRP3 (zeige NLRP3 Antikörper) inflammasome and provides a potential target for intervention of diseases with uncontrolled inflammasome activation.
soluble Tim-3 might play inhibitory roles in impaired Tim-3-mediated clearance of apoptotic cells in systemic lupus erythematosus.
CB2R (zeige CNR2 Antikörper) may have a crucial neuroprotective role following HI insult through the modulation of the inflammatory-related HIF-1alpha (zeige HIF1A Antikörper)/TIM-3 signalling pathway in microglia
demonstrated that both IL-10 (zeige IL10 Antikörper) and TGF-beta (zeige TGFB1 Antikörper) upregulated TIM-3 surface expression on dendritic cells via a common signaling pathway that involved sequential activation of c-Src (zeige SRC Antikörper) and Bruton's tyrosine kinase (zeige BTK Antikörper)
Methylation level of the TIM-3 promoter gradually decreased after each round of T-cell polarization, and this decrease was inversely correlated with TIM-3 expression.
in mice, TIM-3 is not essential for development of HDM (zeige HDAC3 Antikörper)-induced acute or chronic allergic airway inflammation, although it appears to be involved in reduced lymphocyte recruitment during HDM (zeige HDAC3 Antikörper)-induced chronic allergic airway inflammation.
Authors found that a CD8 (zeige CD8A Antikörper)(+) T-cell population with age-associated exhaustion was distinguishable by its expression of Tim-3.
TIM4 (zeige TIMD4 Antikörper) binds TIM3 on the surface of polarized Th1 (zeige HAND1 Antikörper) cells to induce Th1 (zeige HAND1 Antikörper) cell apoptosis, which may contribute to the development of Th2-dominant immune disorders.
The Gal-9 (zeige LGALS9 Antikörper)/Tim-3 signal is important for the regulation of decidua NK cells function, which is beneficial for the maintenance of a normal pregnancy.
TIM-3 expression by NK cells and gamma/delta T cells is similar in the peripheral and decidual immune cells from pregnant mice.
Tim-3 acts at a receptor-proximal point to enhance Lyn (zeige LYN Antikörper) kinase-dependent signaling pathways that modulate both immediate-phase degranulation and late-phase cytokine production downstream of FcepsilonRI (zeige FCER1A Antikörper) ligation.
The protein encoded by this gene belongs to the immunoglobulin superfamily, and TIM family of proteins. CD4-positive T helper lymphocytes can be divided into types 1 (Th1) and 2 (Th2) on the basis of their cytokine secretion patterns. Th1 cells are involved in cell-mediated immunity to intracellular pathogens and delayed-type hypersensitivity reactions, whereas, Th2 cells are involved in the control of extracellular helminthic infections and the promotion of atopic and allergic diseases. This protein is a Th1-specific cell surface protein that regulates macrophage activation, and inhibits Th1-mediated auto- and alloimmune responses, and promotes immunological tolerance.
hepatitis A virus cellular receptor 2
, T cell immunoglobulin mucin 3
, T cell immunoglobulin mucin-3
, T-cell immunoglobulin and mucin domain-containing protein 3
, T-cell membrane protein 3
, kidney injury molecule-3
, T-cell immunoglobulin and mucin domain containing 3
, hepatitis A virus cellular receptor 2 homolog